PAROS
Artificial Intelligence Augmented Radiology solution for prostate MRI
PAROS is an Artificial Intelligence Augmented Radiology solution for prostate MRI. It automatically segments the prostate to estimate its volume. The prostate lesions are detected, segmented, characterized and shown in the PIRADS schema with their respective level of suspicion.
Automatic generation of a pre-filled report
PAROS automatically generates a pre-filled report in “Secondary Capture” format. This report is available on your PACS or review workstation as an additional series.
Overlay of segmented prostate and detected lesions
PAROS outputs an overlay of the segmented prostate and detected lesion(s), together with a heatmap overlay which highlights suspicious areas in the prostate
PAROS enables users to improve their performances in prostate MRI exam interpretation.
PAROS standardizes prostate MRI exam interpretation and enables to structure communication with patients and correspondents.
PAROS saves time in prostate MRI exam interpretation.
Save time, secure your diagnosis and optimize your workflow with Incepto
Publications
-
MRI prostate volume using automatic contour segmentation: multi-constructor development and evaluation, Abstract JFR (2022)
-
Deep learning based algorithm for prostate cancer detection on multi-vendor MRI scans, with focus on how annotator variability affects algorithm performance, Abstract ECR (2023)
-
Prostate cancer detection: comparison of available deep learning methods, Abstract ESUR (2023)
-
Potential benefits of Dynamic Contrast-enhanced MRI as an additional input to biparametric MRI in a deep-learning-based prostate cancer lesion detection algorithm, Abstract EUSOMII (2023)
-
Detection of prostate lesions at risk of cancer on multi-manufacturer MRIs based on deep learning, and analysis of the impact of annotator variability on algorithm performance, Abstract JFR (2023)
-
Impact of an artificial intelligence (AI) software on the diagnostic performance of a junior radiologist in detecting prostate cancer on MRI, Abstract ECR (2024)
Regulatory
Contact us to know if this product is available in your country.